Peptide Drugs intermediate
Liraglutide 3.0mg Obesity
Liraglutide 3.0mg daily for chronic weight management with BMI 30 or BMI 27 with comorbidities.
By Encyclopeptide Editorial | 1 min read
glp1 obesity weight-management
Liraglutide 3.0mg Obesity
Overview
Liraglutide 3.0mg daily for chronic weight management with BMI 30 or BMI 27 with comorbidities.
Structure
| Property | Value |
|---|---|
| Name | Liraglutide 3.0mg Obesity |
Mechanism of Action
Higher dose provides enhanced appetite suppression and satiety signaling.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Liraglutide 3.0mg Obesity |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Liraglutide 3.0mg Obesity with interactive quizzes on Wikipept.
Take a Quiz on Wikipept